NKTX Nkarta, Inc.
Healthcare$3.06+0.99%ClosedMarket Cap: $218.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.79
P/S
0.00
EV/EBITDA
-2.61
DCF Value
$-0.50
FCF Yield
-40.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-30.9%
ROA
-26.9%
ROIC
-32.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-30.9M | $-27.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-31.0M | $-27.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-121.2M | $-104.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-27.3M | $-21.7M | $— | — |
| Q2 null | $0.00 | NaN% | $-27.2M | $-23.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-36.6M | $-32.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-30.9M | $-25.9M | $— | — |
| FY null | $0.00 | NaN% | $-128.2M | $-108.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-33.8M | $-28.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-30.7M | $-25.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-32.8M | $-29.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-31.2M | $-27.8M | $-0.57 | — |